Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Colorcon
Boehringer Ingelheim
AstraZeneca
Express Scripts

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

CLEOCIN Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Cleocin patents expire, and when can generic versions of Cleocin launch?

Cleocin is a drug marketed by Pharmacia And Upjohn and is included in fourteen NDAs. There is one patent protecting this drug.

This drug has twenty-four patent family members in twenty-two countries.

The generic ingredient in CLEOCIN is clindamycin palmitate hydrochloride. There are fifty-five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the clindamycin palmitate hydrochloride profile page.

Drug patent expirations by year for CLEOCIN
Drug Prices for CLEOCIN

See drug prices for CLEOCIN

Drug Sales Revenue Trends for CLEOCIN

See drug sales revenues for CLEOCIN

Recent Clinical Trials for CLEOCIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tianjin Medical University Cancer Institute and HospitalN/A
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Phase 1
Michael Cohen-WolkowiezPhase 1

See all CLEOCIN clinical trials

Pharmacology for CLEOCIN
Synonyms for CLEOCIN
(2S-trans)-Methyl 7-Chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-D-erythro-|A-D-galactooctopyranoside Hydrochloride
(2S-trans)-Methyl 7-Chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-|A-D-galactooctopyranoside Hydrochloride
(2S,4R)-N-((1S,2S)-2-CHLORO-1-((2R,3R,4S,5R,6R)-3,4,5-TRIHYDROXY-6-(METHYLTHIO)TETRAHYDRO-2H-PYRAN-2-YL)PROPYL)-1-METHYL-4-PROPYLPYRROLIDINE-2-CARBOXAMIDE HYDROCHLORIDE
(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride
(2S,4R)-N-[(1S,2S)-2-chloro-1-[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride
17431-55-9
18323-44-9 (Parent)
21462-39-5
26884-28-6
32795-16-7
462C395
58207-19-5
7-Epi Clindamycin Hydrochloride
AB0071584
AB43001
AC-12179
AC1O4WFR
ACT02688
AKOS015843964
AKOS015960823
Antibiotic U 21251F Hydrochloride
Antirobe
Antirobe vet.
API0002053
AS-13649
AT-13884
AUODDLQVRAJAJM-XJQDNNTCSA-N
BCP11950
BenzaClin
BIC0117
C13684
CAS-21462-39-5
CC0172
CCG-212538
CHEMBL1200588
CHEMBL1452303
Cleocin HCl
Cleocin hydrochloride
Cleocin hydrochloride (TN)
Clindamycin (hydrochloride)
CLINDAMYCIN ALCOHOLATE
Clindamycin Hcl
Clindamycin HCl (Dalacin)
Clindamycin hydrochloride
Clindamycin hydrochloride (JP17/USP)
Clindamycin hydrochloride [USP:BAN:JAN]
clindamycin hydrochloride hydrochloride
Clindamycin hydrochloride monohydrate
Clindamycin hydrochloride, European Pharmacopoeia (EP) Reference Standard
Clindamycin hydrochloride, lincosamide antibiotic
Clindimycin hydrochloride
Clinsol
Clintabs
CS-2508
D02132
Dalacin (TN)
DSSTox_CID_25428
DSSTox_GSID_45428
DSSTox_RID_80872
DTXSID4045428
EC 244-398-6
HMS1568K16
HY-B0408A
J10047
MCULE-6809905039
Methyl 7-chloro-6,7,8-trideoxy-6-[(1-methyl-4-propylprolyl)amino]-1-thiooctopyranoside (HCl)
Methyl 7-Chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-D-erythro-|A-D-galactooctopyranoside Hydrochloride
Methyl-7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-?-D-galacto-octopyranoside hydrochloride
MFCD03253991
MFCD07793327
MFCD07793327 (97+%)
MLS000069765
MolPort-003-983-294
NCGC00016752-01
NSC-305832
NSC-756696
NSC305832
NSC756696
Pharmakon1600-01500193
Prestwick_69
SCHEMBL3153
SMR000058902
SR-01000722035
SR-01000722035-3
ST2406750
SY006928
T20OQ1YN1W
Tox21_110591
U 21251F
U-25179E
UNII-T20OQ1YN1W
Z-4007
ZX-AFC000484

US Patents and Regulatory Information for CLEOCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn CLEOCIN clindamycin hydrochloride CAPSULE;ORAL 061809-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn CLEOCIN T clindamycin phosphate GEL;TOPICAL 050615-001 Jan 7, 1987 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn CLEOCIN clindamycin phosphate SUPPOSITORY;VAGINAL 050767-001 Aug 13, 1999 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Pharmacia And Upjohn CLEOCIN clindamycin phosphate CREAM;VAGINAL 050680-002 Mar 2, 1998 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn CLEOCIN PHOSPHATE clindamycin phosphate INJECTABLE;INJECTION 061839-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn CLEOCIN T clindamycin phosphate SOLUTION;TOPICAL 062363-001 Feb 8, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn CLEOCIN clindamycin phosphate SWAB;TOPICAL 050537-002 Feb 22, 1994 AT RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for CLEOCIN

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1304992 122013000081 Germany   Start Trial PRODUCT NAME: CLINDAMYCIN (ALS CLINDAMYCIN-PHOSPHAT) UND TRETINOIN; NAT. REGISTRATION NO/DATE: 85210.00.00 20130611; FIRST REGISTRATION: IRLAND PA1332/043/001 20130322
1304992 C300617 Netherlands   Start Trial PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
1304992 PA2013025,C1304992 Lithuania   Start Trial PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
1304992 SPC/GB13/061 United Kingdom   Start Trial PRODUCT NAME: CLINDAMYCIN PHOSPHATE IN COMBINATION WITH TRETINOIN.; REGISTERED: IE PA1332/043/001 20130322; UK PL15142/0249 20130624
1304992 2013/044 Ireland   Start Trial PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
1304992 CR 2013 00053 Denmark   Start Trial PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
1304992 2013C/060 Belgium   Start Trial PRODUCT NAME: CLINDAMYCINE (ALS CLINDAMYCINE FOSFAAT) EN TRETINOINE; AUTHORISATION NUMBER AND DATE: BE437507 20130506
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Merck
AstraZeneca
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.